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OBJECTIVE—Whether a history of gestational diabetes mellitus (GDM) is associated with an
increased risk of hypertension after the index pregnancy is not well established.
RESEARCH DESIGN AND METHODS—We investigated the association between
GDM and subsequent risk of hypertension after the index pregnancy among 25,305 women
who reported at least one singleton pregnancy between 1991 and 2007 in the Nurses’ Health
Study II.




independent of pregnancy hypertension or subsequent type 2 diabetes.
CONCLUSIONS—TheseresultsindicatethatwomenwithGDMareatasigniﬁcantincreased
risk of developing hypertension after the index pregnancy.
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I
ncreasing evidence suggests the effect
of gestational diabetes mellitus (GDM)
extendsbeyondpregnancyforboththe
mother and child (1). For instance,
w o m e nw i t hah i s t o r yo fG D Ma r ea ta
substantiallyhigherriskoftype2diabetes
(2); small- and large-vessel vascular dys-
function (3); cardiovascular disease; and
metabolic syndrome and its components,
including hypertension (4–7). In the
current study, we examined longitudi-
nally whether GDM is associated with
an increased risk of hypertension later





Our analysis was conducted among the
116,671 participants of the Nurses’
Health Study II, a longitudinal pro-
spective cohort established in 1989 and
described in detail elsewhere (8). Ques-
tionnaires are distributed biennially to
update lifestyle characteristics and
health-related outcomes. Our analysis in-
cluded women if they reported at least
one pregnancy lasting .6m o n t h sb e -
tween 1991 and 2001 and were free of
chronic disease. Participants were cen-
sored during follow-up at death or if they
reported a cardiovascular disease event. In
all, 25,305 participants were included.
Assessment of exposure and
outcome
A physician diagnosis of GDM was ascer-
tainedbyself-reportonbiannualquestion-
naires from 1989 through 2001, and has
been previously validated. GDM is an
established risk factor for type 2 diabetes
(2), which is a well-known correlate of
hypertension. Thus, we recategorized
our exposure in a secondary analysis to
examine the joint effect of GDM and
type 2 diabetes: without self-reported
GDM or type 2 diabetes, GDM only, type
2 diabetes only, or both GDM and subse-
quent type 2 diabetes.
Participantswereaskedoneachques-
tionnaire if they received a physician’s
diagnosis of high blood pressure (yes/
no) and the date of diagnosis, which was
also previously validated. Incident cases
were counted from the ﬁrst follow-
up questionnaire (1993) through June
2007.
Statistical analysis
Participants’ person-time was computed
from the date of questionnaire return re-
porting the index pregnancy until the
date of the diagnosis of hypertension,
date of death or cardiovascular disease
event, or the date of their latest question-
naire return, whichever came ﬁrst. GDM-
exposed person-time was deﬁned from
the date of the ﬁrst reported GDM diag-
nosis through the end of follow-up.
Multivariable Cox proportional haz-
ards models estimated the relative risk
(hazard ratio [HR]) and 95% CI for the
association between GDM and the sub-
sequent risk of hypertension. In addition
to computing an age-adjusted model, we
adjusted for a priori potential confound-
ers of the association between GDM and
hypertension.Weconducted22loglike-
lihood ratio tests to assess whether the
association of GDM with a future risk
of hypertension was modiﬁed by family
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RESULTS—Of the 25,305 participants
included in our analysis, 1,414 (5.6%)
were ﬁrst exposed to GDM during their
index or a subsequent pregnancy.
Women with GDM were generally more
likely to be obese, have a history of
preeclampsia/toxemia, have a family his-
tory of diabetes/hypertension, and were
less likely to perform vigorous physical
activity than women without GDM (Sup-
plementary Table 1).
We documented 3,138 cases of hy-
pertension during 317,892 person-years
of follow-up. The unadjusted incidence
rate of hypertension was 1.76 cases per
100 person-years among women with
GDM, and 0.95 cases per 100 person-
years among the unexposed (Supple-
mentary Fig. 1). Table 1 reports the
age-,BMI-,andmultivariable-adjustedas-
sociations between GDM and incident hy-
pertension. In the multivariable-adjusted
model, the association was signiﬁcant: ex-
posuretoGDMwasassociatedwitha26%
increased risk of hypertension (HR 1.26
[95% CI 1.11–1.43]; P = 0.0004). There
was no evidence of effect modiﬁcation by
family history of hypertension (P = 0.9 for
interaction), race and ethnicity (P = 0.6),
or BMI status (P = 0.3).
Overall, type 2 diabetes developed in
244 participants (1.0%) after the index
pregnancyandbeforehypertensionorthe
end of follow-up (Supplementary Fig. 2),
of whom 114 (47%) had been exposed to
GDM before type 2 diabetes developed.
Compared with participants without ex-
posure to GDM or to type 2 diabetes, the
multivariable HR of incident hyperten-
sion was 2.55 (95% CI 1.84–3.55; P ,
0.0001) among those who had both
GDM and subsequent type 2 diabetes.
This was similar to the HR among women
who had type 2 diabetes only (2.98 [2.17–
4.08]; P , 0.0001). The association be-
tweenGDMandincidenceofhypertension
remained signiﬁcant among the partici-
pants who had GDM but did not subse-
quently develop type 2 diabetes (1.18
[1.03–1.36]; P = 0.02).
CONCLUSIONS—In a large prospec-
tive cohort, we found that women ex-
posed to GDM had an increased risk of
hypertensionintheyearsafterpregnancy,
even after adjusting for other major risk
factors of hypertension. The precise un-
derlying mechanisms for the observed
association are unclear. During a normal
pregnancy, insulin resistance in maternal
tissues occurs to increase the glucose
supply for the developing fetus (9). Pre-
vious research has demonstrated that
women who developed GDM had an
underlying high susceptibility to glucose
tolerance (i.e., b-cell dysfunction and
chronic insulin resistance) such that
they are more likely to develop GDM
when facing the metabolic challenges in
pregnancy. Defects in insulin sensitivity
and secretion are both related to elevated
hypertension risk. It is plausible that the
association of GDM and subsequent hy-
pertension reﬂects pre-existing common
risk factors for both GDM and hyperten-
sion (10,11). It is also biologically plau-
sible that our results reﬂect a causal
association between GDM and subse-
quent hypertension, such that lasting
metabolic and vascular damage inﬂicted
during a pregnancy complicated by GDM
increases the risk that hypertension will
developyears later.However,prospective
studiesevaluatingbiologicriskfactorsbe-
fore, during, and after pregnancy are
needed to further evaluate the causal as-
sociation hypothesis.
Our results indicate that women with
GDM are at a signiﬁcantly increased risk
of hypertension compared with women
w h od on o th a v eG D M .Ad i a g n o s i so f
GDM may provide an opportunity to
intervene with high-risk women years
before hypertension would normally
present. Further research is needed to
understandtheunderlyingbiologicmech-
anisms, as well as to measure the effect
of GDM prevention or postpartum inter-
ventions on the long-term risk of hyper-
tension.
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